Edition:
Deutschland

Asahi Kasei Corp (3407.T)

3407.T on Tokyo Stock Exchange

1,324JPY
16 Feb 2018
Change (% chg)

¥23 (+1.77%)
Prev Close
¥1,300
Open
¥1,320
Day's High
¥1,338
Day's Low
¥1,313
Volume
3,231,200
Avg. Vol
4,081,405
52-wk High
¥1,572
52-wk Low
¥1,004

3407.T

Chart for 3407.T

About

ASAHI KASEI CORPORATION is mainly engaged in chemical business. It has seven business segments. The Chemical segment offers petrochemicals, functional films, functional resins and others. The Textile segment offers synthetic textile and nonwoven fabrics. The Housing segment is engaged in the development and sale of housing, as... (more)

Buy/Sell

Sell Hold Buy
2.69 Mean rating from 13 analysts

Overall

Beta: 0.74
Market Cap(Mil.): ¥1,944,026.00
Shares Outstanding(Mil.): 1,402.62
Dividend: 12.00
Yield (%): 1.73

Asahi Kasei unit wins $400 million U.S. defense contract -Pentagon

WASHINGTON, Dec 8 Zoll Medical Corp, a unit of Asahi Kasei Corp, has been awarded a $400 million contract for deployable vital signs monitors, the Pentagon said on Friday. (Reporting by Mohammad Zargham; Editing by Eric Beech)

Israel's Atox Bio raises $30 mln in Arix Bioscience-led round

JERUSALEM, Dec 4 Israeli biotech firm Atox Bio said on Monday it raised $30 million to further develop its leading product as a kidney treatment, in a fundraising round led by U.K.-based Arix Bioscience.

Photo

Kobe Steel scandal latest to expose 'Made-in-Japan' fault-lines

TOKYO Under the once-vaunted "keiretsu" system of close, trust-based ties between manufacturers and suppliers, "Made-in-Japan" became a byword for industrial quality and reliability.

Kobe Steel scandal latest to expose 'Made-in-Japan' fault-lines

* Markets now more competitive, compliance stricter (Adds graphics)

BRIEF-Bone Therapeutics and Asahi Kasei sign exclusive license agreement for Preob in Japan

* REG-BONE THERAPEUTICS SA AND ASAHI KASEI SIGN EXCLUSIVE LICENSE AGREEMENT FOR PREOB® IN JAPAN

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie -0.07%
Rohstoffe +0.22%
Industrie -0.03%
Konjunktur abhängige Waren & Dienstleistungen +0.66%
Konjunktur unabhängige Waren & Dienstleistungen +0.13%
Finanzindustrie +0.63%
Pharma -0.13%
Technologie +0.52%
Telekommunikation +0.96%

Nachrichten aus der Wirtschaft